Scribd Logo
Upload

Welcome to Scribd!

  • 11 views

    Perspective Management Assignment (64 & 67)

    Uploaded by

    Pratik Gohil

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    Perspective Management Assignment (64 & 67)

    Uploaded by

    Pratik Gohil
    11 views10 pages

    Original Title

    Perspective Management Assignment ( 64 & 67)

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    11 views10 pages

    Perspective Management Assignment (64 & 67)

    Uploaded by

    Pratik Gohil

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    of 10

    THE BIOTECHNOLOGY INDUSTRY IN INDIA

    BY: PRATIK GOHIL (64)


    & RIYA RAINA (67)
    The Biotechnology Industry in India
    The Indian biotechnology industry is experiencing significant growth and is
    expected to continue expanding in the coming years.

    CONTENT :

    • Overview of the industry • R&D expenditure


    • Key segments • Patenting activity
    • Market capitalization • Exports
    • Future outlook
    Industry Overview:

    Growth Potential:

    The Indian biotechnology industry is projected to have a Compound Annual Growth Rate (CAGR)
    of 12.4% from 2022 to 2030, making it one of the fastest-growing sectors in the country.

    The industry is currently valued at $92.3 billion and is expected to reach $150 billion by 2025 and
    an impressive $300 billion by 2030.

    Global Standing:

    India holds a prominent position in the biotechnology landscape, being among the top 12
    destinations worldwide and the third-largest in the Asia Pacific region.
    TOP COMPANIES AND THEIR CONTRIBUTIONS:

    Company Name Products Contribution to the world Revenue

    Developed India's first recombinant insulin


    Biocon Biopharmaceuticals, insulin, statins and statin $2.3 billion

    Biopharmaceuticals, generics, specialty


    Sun Pharma drugs Developed India's first generic AIDS drug $4.5 billion

    Dr. Reddy's Biopharmaceuticals, generics, specialty Developed India's first generic Hepatitis C
    Laboratories drugs drug $3.5 billion
    Key Segments:

    Biopharmaceuticals: Bio-services: Bio-agriculture: Bio-industrials:

    This largest and India is becoming a Meeting the demand for The demand for bio-
    fastest-growing significant player in sustainable and eco- based products,
    segment of the Indian clinical trials and friendly agricultural including biofuels and
    biotechnology industry contract manufacturing practices, this segment bioplastics, has led to
    encompasses over within this rapidly showcases positive growth substantial growth
    50% of the total growing segment. potential. within this segment.
    market.
    Market Capitalization:

    Segment Market Cap

    Biopharmaceuticals $50 billion

    Bio-services $20 billion

    Bio-agriculture $10 billion

    Bio-industrials $5 billion

    Bio-IT $2 billion
    R&D Expenditure:
    Innovation is a driving force in the Indian biotechnology industry, supported by increasing Research and Development (R&D)
    expenditure. In 2022, India's annual spending in biotechnology R&D reached a notable $1.02 billion. This substantial growth
    can be attributed to both government initiatives, including the Biotechnology Industry Partnership Program (BIPP) and the
    Biotechnology Ignition Grant Scheme (BIGS), as well as significant investments from private sector companies such as
    Biocon, Sun Pharma, and Dr. Reddy's Laboratories.

    Patenting Activity:
    India has witnessed a rise in patenting activity in the field of biotechnology, with 56 patents filed or granted in the last three
    years. This surge in patent applications can be attributed to the increasing awareness of intellectual property rights (IPR) and
    the government's efforts to promote innovation. These developments reflect the growing emphasis on protecting intellectual
    assets and fostering a culture of innovation within the industry.
    Exports:
    India has established itself as a major exporter in the biotechnology sector. The country's exports of
    vaccines and biopharmaceuticals reached an impressive $12.3 billion in 2022. Furthermore, India
    has become a preferred destination for clinical trials and contract manufacturing globally, with over
    1,000 clinical trials conducted within the country each year. These export figures exemplify India's
    significant contribution of 3% to the global biotechnology market.

    Future Outlook:
    The Indian biotechnology industry is poised for continued rapid growth in the years ahead. Factors
    driving this growth include increasing demand for healthcare products, rising disposable incomes, and
    robust government support. Moreover, the adoption of cutting-edge technologies, such as artificial
    intelligence (AI) and machine learning (ML), is expected to further propel the industry's advancement.
    With a promising outlook, the Indian biotechnology sector is set to make a lasting impact on both
    domestic and global fronts.
    References:
    • India Brand Equity Foundation (IBEF):

    https://www.ibef.org/industry/biotechnology-presentation

    • Make in India:

    https://www.makeinindia.com/

    • Biotech Sector Analysis:

    https://www.investindia.gov.in/sector/biotechnology
    THANK YOU !

    You might also like